AU716961B2 - Process for preparing solid dosage forms of very low-dose drugs - Google Patents

Process for preparing solid dosage forms of very low-dose drugs Download PDF

Info

Publication number
AU716961B2
AU716961B2 AU67384/96A AU6738496A AU716961B2 AU 716961 B2 AU716961 B2 AU 716961B2 AU 67384/96 A AU67384/96 A AU 67384/96A AU 6738496 A AU6738496 A AU 6738496A AU 716961 B2 AU716961 B2 AU 716961B2
Authority
AU
Australia
Prior art keywords
drug
composition according
carrier
pharmaceutical composition
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU67384/96A
Other languages
English (en)
Other versions
AU6738496A (en
Inventor
Michael Sidney George Clark
Rajinder Kumar
Julia Mary Loudon
Sultan James Manek
Neil Mortimer
James Albert Napper
Karen Triona O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU6738496A publication Critical patent/AU6738496A/en
Application granted granted Critical
Publication of AU716961B2 publication Critical patent/AU716961B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU67384/96A 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs Ceased AU716961B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GB9515624 1995-07-29
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process
GB9606684 1996-03-29
PCT/EP1996/003326 WO1997004750A2 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU20640/00A Division AU751607B2 (en) 1995-07-29 2000-03-03 Method of treatment of dementia

Publications (2)

Publication Number Publication Date
AU6738496A AU6738496A (en) 1997-02-26
AU716961B2 true AU716961B2 (en) 2000-03-09

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67384/96A Ceased AU716961B2 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs

Country Status (25)

Country Link
EP (1) EP0841902A2 (cs)
JP (1) JPH11510493A (cs)
KR (1) KR19990035972A (cs)
CN (1) CN1196677A (cs)
AP (1) AP858A (cs)
AR (1) AR004178A1 (cs)
AU (1) AU716961B2 (cs)
BG (1) BG102266A (cs)
BR (1) BR9609804A (cs)
CA (1) CA2228048A1 (cs)
CZ (1) CZ24798A3 (cs)
DZ (1) DZ2077A1 (cs)
EA (2) EA199901055A1 (cs)
HU (1) HUP9900521A3 (cs)
IL (1) IL122897A0 (cs)
MA (1) MA23953A1 (cs)
MX (1) MX9800809A (cs)
NO (1) NO980384L (cs)
NZ (1) NZ315632A (cs)
OA (1) OA10659A (cs)
PL (1) PL325242A1 (cs)
SK (1) SK11098A3 (cs)
TR (1) TR199800156T1 (cs)
UY (1) UY24297A1 (cs)
WO (1) WO1997004750A2 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
JP2002506031A (ja) 1998-03-11 2002-02-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 組成物
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
DE60139087D1 (de) 2000-12-14 2009-08-06 Ortho Mcneil Janssen Pharm Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form
WO2005097076A2 (en) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Low dose pharmaceutical products

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
EP0392803A1 (en) * 1989-04-13 1990-10-17 Beecham Group p.l.c. Novel compounds
WO1995017168A1 (en) * 1993-12-21 1995-06-29 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
EP0392803A1 (en) * 1989-04-13 1990-10-17 Beecham Group p.l.c. Novel compounds
WO1995017168A1 (en) * 1993-12-21 1995-06-29 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products

Also Published As

Publication number Publication date
UY24297A1 (es) 1997-01-23
PL325242A1 (en) 1998-07-06
EA000740B1 (ru) 2000-02-28
CA2228048A1 (en) 1997-02-13
AP858A (en) 2000-07-12
NO980384L (no) 1998-03-26
EA199800179A1 (ru) 1998-10-29
SK11098A3 (en) 1998-07-08
CZ24798A3 (cs) 1998-06-17
MA23953A1 (fr) 1997-04-01
OA10659A (en) 2002-09-18
WO1997004750A2 (en) 1997-02-13
MX9800809A (es) 1998-04-30
AP9801170A0 (en) 1998-01-31
KR19990035972A (ko) 1999-05-25
NZ315632A (en) 1999-11-29
HUP9900521A2 (hu) 1999-06-28
NO980384D0 (no) 1998-01-28
EA199901055A1 (ru) 2000-06-26
EP0841902A2 (en) 1998-05-20
AU6738496A (en) 1997-02-26
TR199800156T1 (xx) 1998-04-21
DZ2077A1 (fr) 2002-07-22
JPH11510493A (ja) 1999-09-14
HUP9900521A3 (en) 2001-04-28
BR9609804A (pt) 1999-07-06
IL122897A0 (en) 1998-08-16
AR004178A1 (es) 1998-11-04
BG102266A (en) 1998-10-30
CN1196677A (zh) 1998-10-21
WO1997004750A3 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
JP4868695B2 (ja) 崩壊性が良好な経口製剤
UA72922C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ
KR20130122019A (ko) 약학 조성물
US6100274A (en) 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US20030129246A1 (en) Process for preparing solid dosage forms of very low-dose drugs
JP2010265329A (ja) ８−クロロ−６，１１−ジヒドロ−１１−（４−ピペリジリデン）−５Ｈ−ベンゾ［５，６］シクロヘプタ［１，２−ｂ］ピリジンの経口用組成物
EP0862421B1 (en) Prompt-release pharmaceutical compositions
KR102363727B1 (ko) 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법
AU716961B2 (en) Process for preparing solid dosage forms of very low-dose drugs
TWI426913B (zh) 提昇水懸浮性之細粒劑
JP4750946B2 (ja) 薬学的処方物
MXPA98000809A (en) Procedure to prepare forms of solid doses of very low dose of farm
CN105407875A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
AU611740B2 (en) Pharmaceutical composition and process for its preparation
AU751607B2 (en) Method of treatment of dementia
JPH08325142A (ja) ヨウ化イソプロパミド含有製剤
KR20190007896A (ko) 솔리페나신 또는 이의 약제학적으로 허용가능한 염을 포함하는 구강 붕해정 및 이의 제조방법
JP2002138034A (ja) 苦味マスキングチュアブル錠およびその製造方法
CA2603316C (en) Combined-step process for pharmaceutical compositions
SK15612000A3 (sk) Perorálne tablety s riadeným uvoľňovaním farmaceuticky akceptovateľných solí metoprololu a spôsob ich prípravy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired